Full-text search

Results for “Citigroup Inc”

Search across the indexed text of every released document.

Names that match “Citigroup Inc”

HBRK Associates Inc · 73 ROYAL SAXON INC CO-OP · 59 REGENCY OF PALM BEACH INC · 52 PARK PLACE INC CO-OP · 27 New York Post Publishing INC · 18 USA Inc · 15

1,420 documents found

Inc. Diagnostics & Infrastructure 2007 9A 0.8 - 0.8 0.08 0.08 NM

document Proteogenix House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Diagnostics & Infrastructure 2007 9A 0.8 - 0.8 0.08 0.08 NM

Inc. Therapeutics 2008 10.7 19.2 22.5. 41.7 1.79 3.89 42.0%

document Stromedix House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2008 10.7 19.2 22.5. 41.7 1.79 3.89 42.0%

Inc Therapeutics 2005 15.6 7.1 - 7.1 0.46 0.46 -11.5%

document Transcept Pharmaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc Therapeutics 2005 15.6 7.1 - 7.1 0.46 0.46 -11.5%

Inc. Healthcare Devices 2006 24.7 - 35.4 35.4 - 1.43 6.1%

document Access Closure House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Healthcare Devices 2006 24.7 - 35.4 35.4 - 1.43 6.1%

Inc. Therapeutics 2006 6.2 - 6.8 6.8 - 1.11 1.5%

document Concert Pharmaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2006 6.2 - 6.8 6.8 - 1.11 1.5%

Inc. Healthcare Devices 2005 13.0 - 20.2 20.2 - 1.56 7.1%

document Direct Flow Medical House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Healthcare Devices 2005 13.0 - 20.2 20.2 - 1.56 7.1%

Inc. Healthcare Devices 2008 10.1 - 9.7 9.7 - 0.97 -0.8%

document IlluminOss Medical House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Healthcare Devices 2008 10.1 - 9.7 9.7 - 0.97 -0.8%

Inc. Therapeutics 2007 36.9 - 186.9 186.9 - 5.06 39.9%

document Intarcia Therapeutics House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2007 36.9 - 186.9 186.9 - 5.06 39.9%

Inc. Therapeutics 2007 23.7 - 61.8 61.8 - 2.60 27.5%

document Relypsa House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2007 23.7 - 61.8 61.8 - 2.60 27.5%

Inc. Therapeutics 2005 19.6 - 7.2 Pd. - 0.37 -14.6%

document Tioga Pharmaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2005 19.6 - 7.2 Pd. - 0.37 -14.6%

Inc. Therapeutics 2006 19.4 - 19.6 19.6 - 1.01 0.2%

document VaxInnate House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2006 19.4 - 19.6 19.6 - 1.01 0.2%

USA Inc. would have needed to raise individual income tax rates by

document time charges) House Oversight Committee — Epstein Estate Records (Nov 2025)

USA Inc. would have needed to raise individual income tax rates by

USA Inc. will not be immune to the sudden crises that have afflicted others

document IMAGES-006-HOUSE_OVERSIGHT_020841.txt,With these trends House Oversight Committee — Epstein Estate Records (Nov 2025)

USA Inc. will not be immune to the sudden crises that have afflicted others

Enterprise Strategic Planning Aetna Inc. USA

document Michael Flammini Head House Oversight Committee — Epstein Estate Records (Nov 2025)

Enterprise Strategic Planning Aetna Inc. USA

EMEA and Asia Pacific SAS Institute Inc. USA

document Mikael Hagström President House Oversight Committee — Epstein Estate Records (Nov 2025)

EMEA and Asia Pacific SAS Institute Inc. USA